Functional differences between the Oct2 transactivation domains determine the transactivation potential of individual...

Area of Science:

• Molecular Biology
• Cell Biology
• Immunology

Background:

• Oct2 is a lymphocyte-specific transcription factor crucial for B-cell gene expression.
• Previous studies indicated Oct2 has two transactivation domains with potential redundancy and cell-type specificity.

Purpose of the Study:

• To dissect the transactivation potential of individual Oct2 domains.
• To investigate the B-cell specificity and regulation of Oct2's transactivation capabilities.

Main Methods:

• Utilized Gal4 DNA-binding domain fusion proteins to isolate Oct2 domain function.
• Performed mutational analyses on Oct2's C-terminal transactivation domain.
• Characterized N-terminal regions of Oct2 isoforms, including potential negative regulatory domains.

Main Results:

• Both N- and C-terminal domains independently activate transcription from proximal positions.
• Only the C-terminal domain activates transcription from distant enhancer positions, and this activity is B-cell restricted.
• The C-terminal domain's activity is sensitive to specific C-terminal deletions, indicating a composite structure.
• An N-terminal Negative Regulatory Domain (NRD) in the Oct2.3 isoform can inactivate adjacent transactivation domains and affects protein phosphorylation.

Conclusions:

• Oct2's transactivation potential is modular, with distinct roles for N- and C-terminal domains.
• The C-terminal domain mediates long-range activation in a B-cell-specific manner.
• Alternative splicing and negative regulatory elements, potentially involving phosphorylation, contribute to Oct2's complex regulation.